Unul din obiectivele principale ale Life4me+ - să prevină apariția unor noi cazuri de infecție cu HIV, boli cu transmitere sexuală (TBS), hepatită C și tuberculoză

Aplicația permite stabilirea unei comunicări anonime între medici și persoane care au HIV. Îți permite să organizezi mai ușor programul de administrare a tratamentului și să setezi notificări personalizate și discrete

Toate știrile / Ianuarie 2017

Arhivă

✕

25 ianuarie 2017

3789

WTO to allow poor countries to import generics

WTO to allow poor countries to import generics

The amendment to the Trade Related Aspects of Intellectual Property (TRIPS) is now allowed poor countries to import generic drugs.Two-thirds of WTO members agreed a deal that a lot of people around the world were waited for almost a decade. World Trade Organization (WTO) ...

24 ianuarie 2017

3548

Ireland continues its support for The Global Fund

Ireland continues its support for The Global Fund

The Global Fund to Fight AIDS, TB, and Malaria was founded in 2002. More than 4 million people died from these three diseases that year. Since then the number of AIDS related deaths has dropped by 45% in countries where the Global Fund works, while the number of deaths from ...

24 ianuarie 2017

4109

Researchers: Opioid agonist therapy would have health benefits and highly cost-effective in Russia

Researchers: Opioid agonist therapy would have health benefits and highly cost-effective in Russia

Despite the fact that The World Health Organization (WHO) has endorsed opioid agonist therapy (OAT) and harm reduction and included methadone in its list of essential medication, it’s not yet available in Russia Federation. Methadone is used by 59 countries and regarded ...

23 ianuarie 2017

3753

Study: Small incentives improve patient’s adherence

Study: Small incentives improve patient’s adherence

Adherence to antiretroviral therapy (ART) remains one of the crucial factors to the successful treatment of HIV infection. According to research published in the online edition of AIDS, the provision of regular low-value economic incentives can help to improve adherence ...

23 ianuarie 2017

4004

CDC plans to spread knowledge about PrEP among African-American women

CDC plans to spread knowledge about PrEP among African-American women

Pre-exposure prophylaxis medication, which was developed by Gilead and is sold under the brand name Truvada, was approved by the Food and Drug Administration in 2012 as a one-a-day pill regiment to prevent the spread of HIV infection. It is estimated by several major studies ...

23 ianuarie 2017

3712

Study:Antiviral drugs for Hepatitis C treatment could help with cognitive impairment

Study:Antiviral drugs for Hepatitis C treatment could help with cognitive impairment

According to several studies Hepatitis C viral replication might be associated with neuroinflammation and could result in cognitive deficits in patients with the Hepatitis C virus, with or without HIV co-infection. Also some studies have shown that cognitive deficits are ...

22 ianuarie 2017

3792

Egypt: Near a million treated for Hepatitis C in two years

Egypt: Near a million treated for Hepatitis C in two years

Egypt has one of the world’s highest incidence rates of hepatitis C, a disease that damages your liver and causes cirrhosis and cancer. It is estimated that about 7 per cent of its population of 90 million have the virus. However, the majority of the 5m-6m Egyptians infected ...

20 ianuarie 2017

4391

European Medicines Agency has validated its MAA for new Gilead’s pill for Hepatitis C treatment

European Medicines Agency has validated its MAA for new Gilead’s pill for Hepatitis C treatment

Gilead Sciences, Inc. announced this Friday that the company’s Marketing Authorization Application (MAA) for the investigational, once-daily, single tablet regimen of sofosbuvir 400 mg, velpatasvir 100 mg and voxilaprevir 100 mg (SOF/VEL/VOX) for the treatment of chronic ...

20 ianuarie 2017

3554

Research:Inactivation of particular genes would protect T cells from HIV

Research:Inactivation of particular genes would protect T cells from HIV

Scientists at the Ragon Institute of MGH, MIT and Harvard, in an article published in Nature Genetics, stated that they have discovered genes in the human body that might be used in a future gene therapy-based HIV treatment.

19 ianuarie 2017

3761

Study: Direct transmission drives drug-resistant TB epidemic

Study: Direct transmission drives drug-resistant TB epidemic

A study funded by the National Institute of Health and conducted by researchers from Emory University, CDC, Albert Einstein College of Medicine, and the University of KwaZulu Natal in South Africa was published this week in The New England Journal of Medicine.

1 2 3 4 5